Trial Profile
A Multi-center, Multinational, Randomized, Double-blind, Controlled, Dose Comparison Study to Evaluate Safety and Efficacy of MP4OX Plus Standard Treatment, in Severely Injured Trauma Subjects With Lactic Acidosis Due to Hemorrhagic Shock
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2013
Price :
$35
*
At a glance
- Drugs Human haemoglobin (Primary)
- Indications Haemorrhagic shock; Lactic acidosis
- Focus Therapeutic Use
- Sponsors Sangart
- 14 Nov 2013 New trial record